Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fr…
Industry Peers
Medical Care Facilities| Headline | Source | Time |
|---|---|---|
Yesterday | ||
This week | ||
Older | ||
DDer Aktionär | ||
AAriva | ||
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. | ||
PPresseBox | ||
Fresenius SE & Co KGaA (FSNUY) (Q2 2026) Earnings Call Highlights: Raises Full-Year EPS ... Fresenius SE & Co KGaA (FSNUY) delivers robust first-half results, lifting core EPS growth outlook to 10%-15% as biopharma surges 38% and Helios maintains resilient margins. | ||
Health Care Roundup: Market Talk Find insight on Fresenius, Sandoz, Novo Nordisk and more in the latest Market Talks covering health care. | ||
DDer Aktionär | ||
FTSE 100 Live: Next and Glencore provide results boost, SpaceX tumbles FTSE 100 up 19 points to 10,899 Oil prices waver as Hormuz deal mooted SpaceX's earnings beat runs into a $116bn problem Next, Glencore, Legal & General, 4imprint, S4 Capital among results S&P services PMI due today 9.43am: Some L&G analysis L&G shares fell 1.2%... | ||